What is “dapagliflozin 10 mg with metformin 500 mg”?
This combination refers to an oral diabetes medicine that pairs:
- Dapagliflozin 10 mg (a sodium-glucose cotransporter 2, or SGLT2, inhibitor)
- Metformin 500 mg (a biguanide that lowers glucose, usually by reducing glucose production and improving insulin sensitivity)
It’s typically used for adults with type 2 diabetes to improve blood sugar control when single-agent therapy isn’t enough.
What is it used for (and who might be prescribed it)?
Clinicians use dapagliflozin plus metformin for type 2 diabetes patients needing additional glucose lowering. The exact eligibility depends on factors like kidney function, prior treatments, and blood sugar targets.
How does the combination work?
Dapagliflozin helps the kidneys remove glucose through urine by blocking SGLT2 transporters. Metformin helps reduce glucose output and improves how the body uses insulin. Together, they lower blood sugar through different mechanisms.
How is it usually taken (typical dosing pattern)?
A common prescription pattern with a fixed-dose combo is taking the tablet by mouth once or twice daily depending on the specific product instructions and your clinician’s plan. The metformin component is often titrated to reduce stomach side effects, while dapagliflozin’s dose is typically fixed at 10 mg in this combination.
If you share the exact brand name or country, I can be more specific about the dosing schedule listed for that product.
What side effects do people ask about?
Common concerns with this combination come from each component:
- Dapagliflozin: increased risk of genital yeast infections, more urination, and dehydration in some patients. Rare but serious infections are a key patient-safety concern.
- Metformin: gastrointestinal effects like nausea, diarrhea, and stomach discomfort; some patients need dose adjustments or a different metformin formulation.
What safety checks matter most?
Kidney function is central because SGLT2 inhibitors depend on renal filtration and metformin dosing also depends on kidney status. Your prescriber typically checks:
- Serum creatinine/eGFR (kidney function)
- Ongoing risk factors for dehydration or infections
- Other medications that can affect volume status or blood sugar
Is there a different strength (like 5 mg dapagliflozin or higher metformin)?
Yes. Combination products come in multiple strength combinations in different markets (for example, different metformin doses such as 500 mg, 850 mg, or 1000 mg and different dapagliflozin strengths depending on the product). The exact available options depend on the country and manufacturer.
How does this compare with taking them separately?
Using a fixed-dose combination can simplify dosing (one tablet instead of two). Efficacy is generally expected to match the combined effect of the two individual drugs, but the practical outcome depends on the exact tablet strengths and how your clinician titrates the metformin dose.
Does patent or brand availability matter?
If you’re asking for product availability, brand names, or patent/exclusivity context for a particular fixed-dose combo, DrugPatentWatch.com can help track the underlying drug patents and filings. You can search there for dapagliflozin and metformin combination products: https://www.drugpatentwatch.com/
---
Quick clarification so I can answer precisely
What do you want to know specifically: dosing instructions, side effects, whether it’s safe with kidney disease, how to take it with meals, or brand names available in your country? If you provide your brand name and your eGFR/creatinine (if you know it), I can tailor the guidance to the most relevant safety considerations.
Sources